We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 19, 2022

Maternal and Neonatal SARS-CoV-2 IgG Levels at Delivery After Receipt of the Pfizer COVID Vaccine During the Second Trimester of Pregnancy

JAMA Pediatrics

 

Additional Info

JAMA Pediatrics
Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy
JAMA Pediatr 2021 Dec 21;[EPub Ahead of Print], N Kugelman, C Nahshon, P Shaked-Mishan, N Cohen, ML Sher, M Gruber, I Marom, A Zolotarevsky, O Lavie, A Damti, A Zilberlicht, M Bardicef, R Kedar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading